91
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

Temporal Arteritis—Reversal of Blindness Using Anticoagulation and Steroids

, , , &
Pages 264-268 | Received 14 Jun 2011, Accepted 03 Aug 2011, Published online: 02 Dec 2011
 

Abstract

The aim of the report is to document two cases of biopsy-proven temporal arteritis, resulting in major visual loss that recovered almost completely after treatment with intravenous methylprednisolone and intravenous heparin infusion. An 80-year-old Caucasian lady presented with vision of perception of light (PL) due to a central retinal artery occlusion. Following systematic treatment with anterior chamber paracentesis, intravenous heparin, and intravenous steroids, vision improved to 6/5. A definitive diagnosis was made following temporal artery biopsy. A 77-year-old Caucasian lady presented with treated polymyalgia rheumatica, which on further history and examination was confirmed to be temporal arteritis. Prompt treatment of her arteritic anterior ischaemic optic neuropathy with intravenous methylprednisolone and intravenous heparin infusion resulted in improvement of visual acuity from 6/12 to 6/5 with a sustained improvement in visual fields and in the funduscopically visible optic nerve ischaemic changes. The authors conclude that near-complete resolution of major visual loss in these two patients with biopsy-proven temporal arteritis suggests that the appropriate use of a therapeutic intravenous methylprednisolone and heparin protocol could represent a way forward in the management of this potentially blinding disease. This would need to be confirmed in large prospective, randomised controlled studies.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Note: and of this article are available in colour online at www.informahealthcare.com/oph

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.